Harvested twice a year from the core of two working reactors on a Canadian lake, rods supplying roughly half the world’s medical cobalt now sterilize surgical gloves and syringes worldwide
Twice a year, a crane lowers a rack of pencil thin metal rods into the heart of a running nuclear reactor on the shore of Lake Huron.
Nobody there is making electricity in that moment.
They are growing something else entirely, one neutron at a time.
The arrangement works because a byproduct nobody originally designed the reactor to make turned out to be worth protecting as carefully as the electricity itself.
Eighteen months later those rods are sealed, shipped and used to sterilize the gloves, syringes and surgical kits hospitals across several continents depend on.
Almost nobody using that sterile equipment ever learns where the process actually starts.
So how does a power station end up manufacturing a medical ingredient on the side?
How a power reactor grows a medical ingredient on purpose
The trick starts with an ordinary metal called cobalt 59, which is stable and harmless and sits in nature without doing much of anything. Engineers load it into specially designed rods called adjuster bundles, which already have a job inside a heavy water reactor shaping how the core burns.
Because they already sit inside the neutron rich heart of the reactor, operators can swap some bundles for cobalt 59 instead of the usual steel. That lets the reactor’s own neutrons do work they were producing anyway.
Over months of bombardment, some of that cobalt 59 absorbs a neutron and becomes cobalt 60, an isotope that barely exists in nature. The reactor is never diverted from its main purpose, and it keeps making electricity for the grid exactly as designed.
The isotope production rides along as a parallel process, using neutrons that would otherwise just be absorbed by ordinary metal.
A lake, two reactor buildings and a rack of slender rods
The site is the Bruce Power station on the shore of Lake Huron in Ontario, home to eight reactor units built into the Canadian Shield bedrock. Two of those units are licensed to carry cobalt adjuster bundles, and the operator describes the setup as turning spare reactor capacity into a dedicated isotope factory running alongside full scale power generation.
Each bundle holds a cluster of rods roughly the width of a pencil. Technicians handle the finished material entirely by remote tooling and heavy shielding, since cobalt 60 is intensely radioactive once it has matured inside the core.
Once removed, the rods are cut, encapsulated in stainless steel and shipped in shielded flasks to processing facilities. From there the sealed sources travel to hospitals, blood banks and medical device plants, where their gamma radiation does the sterilizing work without the product ever touching a chemical bath.
The volume behind a word most people have never heard
Bruce Power has said its reactors supply a significant share of the world’s medical and industrial cobalt 60, used to sterilize an enormous share of single use medical devices sold globally each year, from surgical gloves to IV sets. One harvest from a single unit was enough on its own to sterilize 10 billion items of medical equipment, and the company has described the program as helping meet roughly half of global demand for the isotope.
A senior Bruce Power executive overseeing the isotope program has described the work as turning a nuclear station into an engine for global public health. That framing is not marketing gloss, since the physics genuinely does ride for free on a process the plant would run anyway to keep the lights on.
Independent reporting on medical isotope supply has repeatedly flagged how concentrated this production is, with a handful of reactors worldwide carrying outsized responsibility for a material hospitals cannot easily substitute.
Where the arrangement gets harder than it sounds
None of this is as simple as swapping metal and waiting. Cobalt 60 decays on its own clock, losing roughly half its strength every five years, which means supply has to stay continuous rather than stockpiled far in advance the way some industrial materials can be.
That decay schedule ties isotope output directly to reactor uptime. When a unit goes down for planned maintenance, the cobalt harvest pauses too, and because the rods need many months inside the core to reach useful strength, there is no quick way to make up a missed cycle, the kind of unplanned pause documented after one reactor trip elsewhere.
The broader fleet of heavy water reactors able to host these rods is also aging. That raises longer term questions about where the next generation of cobalt 60 capacity will come from, a concern that echoes planning debates around entirely new builds, including the long lead procurement now underway for a first reactor project abroad.
What a sterile glove owes to a reactor nobody pictures
The arrangement works because a byproduct nobody originally designed the reactor to make turned out to be worth protecting as carefully as the electricity itself. Hospitals rarely think about where a sterile package came from, and that invisibility is arguably the clearest sign the system works.
It also says something about how differently a reactor core can be read depending on what a utility chooses to look for inside it. Bruce Power’s own statements frame the cobalt output as a deliberate complement to its generating mission rather than an afterthought.
Other reactors in Russia and elsewhere also contribute meaningful volumes, so no single plant holds a monopoly on keeping operating rooms sterile. Even so, the picture of a nuclear station on a Canadian lake underwriting a slice of global surgery is a genuinely strange and useful turn for machinery built, on paper, to do nothing more than boil water and spin a turbine.
Hugo is an engineer with strong technical expertise. Multilingual from an early age, his writing combines technical clarity with a strong interest in science and energy.
